Key result
Hybrid and surgical ablation reduce atrial arrhythmia recurrence by ~64%.
Why the study?
Selecting the optimal AF rhythm-control modality for an individual patient remains challenging given differences in atrial substrate, comorbidities, AF chronicity, and procedural risk. Understanding how newer technologies like PFA perform alongside established thermal, hybrid, and surgical approaches across different patient profiles is essential for individualized therapy selection.
Do contemporary atrial fibrillation ablation strategies (surgical, hybrid, thermal, and pulsed field ablation) reduce atrial arrhythmia recurrence compared to each other or medical therapy in patients with atrial fibrillation?
Meta-Analysis (n=5,532)
Do contemporary atrial fibrillation ablation strategies (surgical, hybrid, thermal, and pulsed field ablation) reduce atrial arrhythmia recurrence compared to each other or medical therapy in patients with atrial fibrillation?
In a network meta-analysis of 36 RCTs, hybrid and surgical ablation demonstrated the highest efficacy in reducing atrial arrhythmia recurrence—especially in older patients and those with persistent or long-standing AF—while pulsed field ablation showed comparable efficacy and safety to thermal ablation.
Answers are grounded in this paper and cite their sources.
Hybrid and surgical ablation may be prioritized for persistent AF; extends network evidence ranking all modalities versus medical therapy.
Background Atrial fibrillation (AF) can be treated using several rhythm-control strategies, yet selecting the optimal modality for an individual patient remains challenging. Patients differ in atrial substrate, comorbidities, AF chronicity, and procedural risk. As newer technologies such as pulsed field ablation (PFA) are increasingly used alongside established thermal, hybrid, and surgical approaches, understanding how these modalities perform across different patient profiles is essential for individualized therapy selection. Objective To compare the efficacy and safety of contemporary AF ablation strategies—surgical, hybrid, thermal, and PFA—as well as medical therapy. Methods We searched PubMed, Scopus, Web of Science, and Cochrane databases from inception through August 2025 for randomized controlled trials (RCTs) evaluating at least one AF ablation modality versus another or medical therapy. The primary efficacy endpoint was atrial arrhythmia recurrence; secondary endpoints included freedom from atrial tachyarrhythmia, serious adverse events (SAEs), and all-cause mortality. Subgroup analyses were performed by age (<60 vs ≥60), AF type (paroxysmal vs persistent), and AF chronicity (<3 vs ≥3 years). A frequentist random-effects network meta-analysis (NMA) was conducted in R. Results Thirty-six RCTs involving 5,532 patients were included. Hybrid and surgical ablation produced the greatest reductions in arrhythmia recurrence (RR 0.36, 95% CI 0.18–0.73; and RR 0.36, 95% CI 0.15–0.91) (Figure 1A). These benefits were most pronounced in older patients, in persistent AF, and in those with AF duration ≥3 years (Figure 2). Hybrid ablation also trended toward higher freedom from atrial tachyarrhythmia, though not statistically significant (Figure 1B). Both hybrid and surgical approaches showed numerically higher but nonsignificant SAE rates (RR 2.66 and RR 2.60, respectively) (Figure 1C). PFA demonstrated efficacy and safety comparable to thermal ablation. Medical therapy ranked lowest for rhythm control but had the most favorable safety profile. Mortality was similar across treatment arms (Figure 1D). Conclusion Hybrid and surgical ablation provide the highest efficacy—particularly in older patients and those with persistent or long-standing AF—though with a potential trade-off of increased procedural risk. PFA performs similarly to thermal ablation across major endpoints, while medical therapy remains the safest but least effective option. Future studies should focus on tailoring ablation strategy to patient-specific characteristics to optimize individualized AF management.
No takes yet. Share an insight, caveat, or question.
Abdelsayed et al. (2026) conducted a meta-analysis in Atrial fibrillation (n=5,532). AF ablation strategies (hybrid, surgical, thermal, and pulsed field ablation) vs. Medical therapy or alternative AF ablation modalities was evaluated on Atrial arrhythmia recurrence (RR 0.36, 95% CI 0.18-0.73). Hybrid and surgical ablation produced the greatest reductions in atrial arrhythmia recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: